Daniel Gesua Sive Salvadori - Jan 30, 2025 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role: EXECUTIVE VICE PRESIDENT
Signature: /s/ Daniel Gesua Sive Salvadori by Jessica H. Paik, Attorney-in-Fact
Stock symbol: ABT
Transactions as of: Jan 30, 2025
Transactions value $: -$2,141,767
Form type: 4
Date filed: 1/31/2025, 07:08 PM
Previous filing: Mar 4, 2024
Next filing: Feb 27, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABT	Common shares without par value	Options Exercise	$913K	+23.8K	+18.91%	$38.40	149K	Jan 30, 2025	Direct
transaction	ABT	Common shares without par value	Sale	-$3.05M	-23.8K	-15.9%	$128.50	126K	Jan 30, 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABT	Option (right to buy)	Options Exercise	$0	-23.8K	-100%	$0.00	0	Jan 30, 2025	Common Shares	23.8K	$38.40	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.